FIELD: medicine.
SUBSTANCE: method for sampling a lactic acid bacterial strain effective for treating intestinal motility disorder is disclosed. Said method comprises: a) a stage of space-time (ST) mapping, which is carried out on the gastrointestinal segment in order to analyze the effect of said lactic acid bacterial strain on gastric and intestinal motility; b) a stage of detecting the nerve bundle ex vivo, which is carried out on the gastrointestinal segment in order to analyze the effect of the said lactic acid bacterial strain on the passage of pulses on the mesenteric afferent nerves; and c) a step for selecting a bacterial strain effective for treating intestinal motility disorder in accordance with the selection criteria based on the effects of said agent on gastric and intestinal motility and on the mesenteric afferent nerve impulses analyzed at step (a) and step (b), where the selection criteria vary depending on the motility disorder, which is desirably to be treated. Also disclosed are bacterial strains of Lactobacillus gasseri LG345A (DSM 27123) and Lactobacillus gasseri LG621A (DSM 27126) selected using the method of the invention, and use of said strains in treating intestinal motility disorders.
EFFECT: invention provides selection of lactic acid bacterial strain effective for treating intestinal motility disorder.
23 cl, 9 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
SELECTING AGENTS MODULATING GASTROINTESTINAL PAIN | 2015 |
|
RU2692671C2 |
METHOD OF REDUCING MANIFESTATION OF NON-MOTOR SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE | 2019 |
|
RU2734718C1 |
USING LACTOBACILLUS PARACASEI CNCM I-2116 TO TREAT IRRITABLE BOWEL SYNDROME | 2003 |
|
RU2490325C2 |
PROBIOTICS FOR INTESTINE NEUROMUSCULAR FUNCTION | 2003 |
|
RU2346036C2 |
BACTERIA Lactobacillus reuteri STRAIN FOR MAKING PROBIOTIC PRODUCT, AND PROBIOTIC PRODUCT CONTAINING IT | 2007 |
|
RU2435844C2 |
SELECTION AND USE OF MELATONIN-PROVIDING BACTERIA FOR REDUCTION OF INFANT COLIC | 2019 |
|
RU2815940C2 |
METHOD OF PRODUCING AT LEAST ONE NON-ALLERGENIC PROBIOTIC BACTERIAL CULTURE FOR PRODUCING FOOD PRODUCT OR PHARMACEUTICAL COMPOSITION FOR PERSONS SUFFERING FROM COELIACS DISEASE AND ESPECIALLY SENSITIVE TO ALLERGENIC SUBSTANCES OF GLUTEN AND/OR LACTIC TYPE (VERSIONS) | 2006 |
|
RU2410423C2 |
USING LACTOBACILLUS PLANTARUM FOR PROVIDING BACTERIAL DIVERSITY | 2008 |
|
RU2521364C2 |
COMPOSITION CONTAINING N-ACETYLCYSTEINE IN COMBINATION WITH PROBIOTIC BACTERIA ABLE TO RESTORE THEIR OWN STOMACH BARRIER EFFECT LOST PHARMA DURING PHARMACOLOGICAL TREATMENT OF GASTRIC HYPERACIDITY | 2012 |
|
RU2617952C2 |
PROBIOTIC STRAIN LACTOBACILLUS GASSERI AND ITS COMPOSITION WITH LACTOFERRIN FOR PREVENTION OF DIARRHEA, NERROCESSING ENTERHEROLITE AND SEPISIS CAUSED BY ESCHERICHIA COLI STRAINS IN PREMATURELY BORN CHILDREN | 2016 |
|
RU2641258C1 |
Authors
Dates
2019-09-26—Published
2013-09-03—Filed